Key facts
- RxDiet’s last known valuation is $12.8M (Aug 2022).
- It has raised $4.7M; the latest was Later Stage VC in Jan 2025.
- Notable investors include Plug and Play Tech Center, SOSV, Immad Akhund, Giant Ventures, Better Ventures — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for RxDiet
- ·The full record, as it builds
Funding rounds
No funding rounds for RxDiet are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RxDiet
Developer of a nutritional guidance platform designed to provide health plans. The company's tool uses artificial intelligence to create patient surveys and a personalized program as per cultural and lifestyle preferences to provide fresh groceries, enabling users to maintain a healthy and balanced diet at lower costs.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2018
- Employees
- 25
- Website
- rx-diet.com/
- Ownership
- Privately Held (backing)
RxDiet doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RxDiet shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RxDiet in its N-PORT filings yet. We sweep new filings monthly.